col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Kare Publishing: Eurasian Journal of Medicine and Oncology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―26 Dissecting the Thrombotic Events in the Presence of Antiphospholipid Antibodies in COVID-19 Spanish Patients claudia geraldine rita
2 [GO] 2021―Jul―26 In Silico Characterisation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) based on the Spike Protein Gene ashish warghane
3 [GO] 2021―Jun―23 Forecasting COVID-19 Cases in Egypt Using ARIMA-Based Time-Series Analysis ibrahim sabry
4 [GO] 2021―Jun―23 Evaluation of Parametric Method Performance for Left-Censored Data and Recommendation of Using for Covid-19 Data Analysis mustafa agah tekindal
5 [GO] 2021―Mar―02 Estimation of Death and Recovery Rates using Covid-19 Data of Pakistan muhammad kashif
6 [GO] 2021―Mar―02 Estimation of epidemiological indicators of COVID-19 in Algeria with an SIRD model mohamed lounis
7 [GO] 2021―Mar―02 Psychiatric Disorders and Symptoms in Children and Adolescents During the COVID-19 Pandemic: A Review melike kevser gül
8 [GO] 2021―Mar―02 A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients abu taiub mohammed mohiuddin chowdhury
9 [GO] 2021―Mar―02 Multisystemic Long-Term Sequelae of Covid-19: A Review Based on the Current Literature Over a Year of Pandemic Experience ahmet riza sahin
10 [GO] 2021―Mar―02 Neurotropism of SARS-CoV 2 and others Coronavirus in Children: Mechanisms and Clinical Manifestations silvia marino
11 [GO] 2020―Dec―02 SARS-CoV-2 Related Protein Expression may Predict Vulnerability for Developing COVID-19 in Cancer Patients Ashutosh Kumar
12 [GO] 2020―Dec―02 Interleukin-2 level for normal people and COVID-19 Infection: is it our concern is COVID-19 Infection or Inreleukin-2 level before the infection? Alqaisy Yazan
13 [GO] 2020―Dec―02 Molecular Docking Study of Some Nucleoside Analogs against Main Protease of SARS-CoV-2 Dhiraj Brahman
14 [GO] 2020―Dec―02 Screening of preferential binding affinity of selected natural compounds to SARS-CoV-2 proteins using in silico methods Lejla Pojskic
15 [GO] 2020―Dec―02 Design of CRISPR-Based Targets for the Development of a Diagnostic Method for SARS-CoV-2: An in Silico Approach Chinna Venkateswarulu Thirupati
16 [GO] 2020―Sep―09 Various Evidence-Based Hypothetical and Experimental Treatment Approaches and Their Effectiveness against COVID-19 Worldwide: A Comprehensive Literature Review Muhammad Naveed
17 [GO] 2020―Jul―17 Novel Coronavirus Disease (COVID-19): World’s Past Experience on Deadly Outbreaks Temesgen A. Gelaw
18 [GO] 2020―Jul―17 Bioinformatics Approach for COVID-19 (Coronavirus) Disease Prevention Treatment and Drug Validation Shruti Mishra
19 [GO] 2020―Jul―17 COVID-19 Imaging in a Tertiary Care Setting - The Zurich Approach Andreas Boss
20 [GO] 2020―Jul―17 Epitope-Based Vaccine Design against Novel Coronavirus SARS-CoV-2 Envelope Protein Hanuman Singh Dagur
21 [GO] 2020―May―15 IN Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors Heba E. Hashem
22 [GO] 2020―May―15 A Response to Massimo Bonucci’s Editorial: COVID-19 Outbreak: How to Use Current Knowledge to Better Treat Positive Patients Leung Ping-chung
23 [GO] 2020―May―15 COVID-19 Outbreak: How to Use Current Knowledge to better Treat Positive Patients Massimo Bonucci
24 [GO] 2020―May―15 The Pain of Sending Away Cancer Patients Amidst the COVID-19 Pandemic in Philippines Frederic Ivan Ting
25 [GO] 2020―May―15 Pneumocystis Jiroveci Mimicking COVID-19 Pneumonia in a Patient who Receiving Ipilimumab and Nivolumab Combination Therapy: A Case Report Elissar Moujaess
26 [GO] 2020―May―04 Cytokine-targeted therapy in severely ill COVID-19 patients: Options and cautions Marveh Rahmati
27 [GO] 2020―Apr―29 How to Face with Minimally Invasive Abdominal Surgery During Covid-19 Outbreak? Surgical and Anesthesiological Concerns Mirko Barone
28 [GO] 2020―Apr―29 The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2 Rameshwar S. Cheke
29 [GO] 2020―Apr―17 EDITORIAL: Successful Treatment Strategy of Turkey against Covid-19 Outbreak Hilmi Kodaz
30 [GO] 2020―Apr―16 Recombinant Human Angiotensin-Converting Enzyme 2 and COVID-19 Acute Respiratory Distress Syndrome: A Theoretical or a Real Resource? Mirko Barone
31 [GO] 2020―Apr―16 Genome Organization of Covid-19 and Emerging Severe Acute Respiratory Syndrome Covid-19 Outbreak: A Pandemic Hanuman Singh Dagur
32 [GO] 2020―Apr―16 A Review of COVID-19 (Coronavirus Disease-2019) Diagnosis, Treatments and Prevention Shmmon Ahmad
33 [GO] 2020―Apr―16 Case Fatality Rate estimation of COVID-19 for European Countries: Turkey’s Current Scenario Amidst a Global Pandemic; Comparison of Outbreakswith European Countries Aadil Javed
34 [GO] 2020―Apr―06 The Impacts of Covariates on Spatial Distribution of CORONA Virus 2019 (COVID-19): WHO Data through Multivariate Analysis of Covariance (MANCOVA) Habte Tadesse Likassa
35 [GO] 2020―Apr―06 Double Trouble: Challenges of Cancer Care in the Philippines during the COVID-19 Pandemic Frederic Ivan Ting
36 [GO] 2020―Apr―06 Modeling and Forecasting for the number of cases of the COVID-19 pandemic with the Curve Estimation Models, the Box-Jenkins and Exponential Smoothing Methods Harun Yonar
37 [GO] 2020―Mar―24 Why are Children Less Affected by COVID-19 ? Could there be an Overlooked Bacterial Co-Infection? Ramazan Azim Okyay
38 [GO] 2020―Mar―17 Corona Virus: A Review of COVID-19 Dharmendra Kumar
39 [GO] 2020―Mar―17 The Rise of New Coronavirus Infection-(COVID-19): A Recent Update Suraj N. Mali


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.011 sec